Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1998-12-7
|
| pubmed:abstractText |
Over recent years, significant advances have been made in our knowledge of hepatitis C. Three observe special attention: 1) the possible nosocomial transmission of hepatitis C during invasive investigation; 2) the improved efficacy of bitherapy (interferon with ribavirine) over monotherapy in chronic hepatitis C; 3) the value of interferon therapy in acute hepatitis C before it turns to chronicity.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0370-629X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
53
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
467-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9810206-Acute Disease,
pubmed-meshheading:9810206-Antiviral Agents,
pubmed-meshheading:9810206-Chronic Disease,
pubmed-meshheading:9810206-Combined Modality Therapy,
pubmed-meshheading:9810206-Cross Infection,
pubmed-meshheading:9810206-Disease Progression,
pubmed-meshheading:9810206-Hepatitis C,
pubmed-meshheading:9810206-Humans,
pubmed-meshheading:9810206-Interferons,
pubmed-meshheading:9810206-Ribavirin
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
[Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
|
| pubmed:affiliation |
Service de Gastroentérologie, Université de Liège.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Review
|